Is Enveric Biosciences Inc (ENVB) overvalued? · $3.3M cap
Enveric Biosciences Inc (ENVB) is a biotechnology company listed on US.
This page asks whether Enveric Biosciences Inc (ENVB) looks expensive on cached numbers — not a short thesis.
No cached income statement for ENVB, so there is no earnings base to call rich or cheap.
ENVB currently screens at market cap $3.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ENVB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ENVB stock page for the full model, not this heading.
Not investment advice.